BR9814080A - Uso de compostos para atividade anti-prurìtica - Google Patents

Uso de compostos para atividade anti-prurìtica

Info

Publication number
BR9814080A
BR9814080A BR9814080-9A BR9814080A BR9814080A BR 9814080 A BR9814080 A BR 9814080A BR 9814080 A BR9814080 A BR 9814080A BR 9814080 A BR9814080 A BR 9814080A
Authority
BR
Brazil
Prior art keywords
compounds
pruritic activity
activity
pruritic
pruritically
Prior art date
Application number
BR9814080-9A
Other languages
English (en)
Inventor
Don E Griswold
Siegfried Benjamin Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR9814080A publication Critical patent/BR9814080A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"USO DE COMPOSTOS PARA ATIVIDADE ANTI-PRURìTICA" A presente invenção refere-se a derivados de xantinas 8-substituídas que são usados na profilaxia ou terapida de doenças ou distúrbios que têm um componente prurítico.
BR9814080-9A 1997-10-17 1998-10-16 Uso de compostos para atividade anti-prurìtica BR9814080A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (1)

Publication Number Publication Date
BR9814080A true BR9814080A (pt) 2000-09-26

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814080-9A BR9814080A (pt) 1997-10-17 1998-10-16 Uso de compostos para atividade anti-prurìtica

Country Status (18)

Country Link
EP (1) EP1030666A4 (pt)
JP (1) JP2001520196A (pt)
KR (1) KR20010031149A (pt)
CN (1) CN1306426A (pt)
AR (1) AR015966A1 (pt)
AU (1) AU740875B2 (pt)
BR (1) BR9814080A (pt)
CA (1) CA2306985A1 (pt)
CO (1) CO4810374A1 (pt)
CZ (1) CZ20001376A3 (pt)
HU (1) HUP0003792A3 (pt)
IL (1) IL135581A0 (pt)
NO (1) NO20001847L (pt)
NZ (1) NZ503551A (pt)
PL (1) PL341062A1 (pt)
TR (1) TR200001040T2 (pt)
WO (1) WO1999020280A1 (pt)
ZA (1) ZA989450B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
KR20030070150A (ko) 2001-01-31 2003-08-27 화이자 프로덕츠 인크. Ｐｄｅ4 이소자임 억제제로서 유용한 에테르 유도체
EP1355907A1 (en) 2001-01-31 2003-10-29 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
WO2005007161A1 (ja) * 2003-07-17 2005-01-27 Santen Pharmaceutical Co., Ltd. ピペリジン誘導体を有効成分とする掻痒治療剤
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
AU2005212816C1 (en) * 2004-02-14 2010-03-04 Glaxosmithkline Llc Novel compounds
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
PT1912991E (pt) 2005-08-10 2011-01-17 Glaxosmithkline Llc Derivados de xantina como agonistas selectivos de hm74a
CN101389612B (zh) * 2006-02-21 2011-09-21 卫材R&D管理有限公司 喹唑啉衍生物
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
WO2009025239A1 (ja) 2007-08-17 2009-02-26 Eisai R & D Management Co., Ltd. 新規外用剤
CN102336717B (zh) 2007-08-17 2013-09-18 卫材R&D管理有限公司 喹唑啉衍生物
JP5985475B2 (ja) * 2011-06-28 2016-09-06 田辺三菱製薬株式会社 新規医薬組成物
SI3251675T1 (sl) 2015-01-30 2021-08-31 Shanton Pharma Pte. Ltd. Preprečevanje ali zdravljenje sečnokislinske ali protinske bolezni

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148170T3 (es) * 1990-12-21 2000-10-16 Beecham Group Plc Derivados de xantina.
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
EP0912568B1 (en) * 1996-05-15 2002-11-20 ALTANA Pharma AG imidazopyridines
JP2001514640A (ja) * 1997-03-07 2001-09-11 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のテトラゾール
BR9810409A (pt) * 1997-03-18 2000-08-22 Basf Ag Métodos e composições para a modulação de responsividade a corticosteróides
ATE232864T1 (de) * 1997-06-03 2003-03-15 Altana Pharma Ag Benzonaphthyridine

Also Published As

Publication number Publication date
WO1999020280A1 (en) 1999-04-29
JP2001520196A (ja) 2001-10-30
PL341062A1 (en) 2001-03-26
NO20001847D0 (no) 2000-04-10
NZ503551A (en) 2002-05-31
IL135581A0 (en) 2001-05-20
CZ20001376A3 (cs) 2002-06-12
AU740875B2 (en) 2001-11-15
AU1093899A (en) 1999-05-10
TR200001040T2 (tr) 2001-01-22
CO4810374A1 (es) 1999-06-30
KR20010031149A (ko) 2001-04-16
HUP0003792A3 (en) 2001-12-28
CN1306426A (zh) 2001-08-01
NO20001847L (no) 2000-04-10
HUP0003792A2 (hu) 2001-10-28
ZA989450B (en) 1999-04-19
CA2306985A1 (en) 1999-04-29
EP1030666A4 (en) 2002-10-16
AR015966A1 (es) 2001-05-30
EP1030666A1 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
BR9814080A (pt) Uso de compostos para atividade anti-prurìtica
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
BR0113146A (pt) Derivados de prolina e uso destes como drogas
EP0105635A3 (en) Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therepeutic agents
BR9408407A (pt) Uso de inibidores pla2 como tratamento para doença de alzheimer
BR9812944A (pt) Inibidores bicìclicos da cinase
SV1999000147A (es) Derivados de 4, 4-biarilpiperidina ref. pc10083/82759/bb
DE69333109D1 (de) Therapeutische nukleoside
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
BG101110A (en) Substituted pyrimidine compounds and their application
FI946043A (fi) Sokeripäällysteinen farmaseuttinen annosyksikkö
BR0113590A (pt) 7-oxo-piridopirimidinas
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
PT90743A (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
AU623805B2 (en) New use of anti-progestomimetic compounds
DK102892A (da) Purin-derivater, farmaceutisk praeparat omfattende forbindelserne samt forbindelser til brug som mellemprodukter
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
BR9811631A (pt) Derivado de ácido carboxìlico e uso do mesmo
ES8700257A1 (es) Procedimiento para preparar derivados de pirazol(1,5-a) pi- ridina
ES549983A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.